Facing increased competition in the weight loss market and intense pressure from President Donald Trump, Novo Nordisk ...

Novo Nordisk moved to cut U.S. prices on its leading GLP-1 weight-loss and diabetes drugs as competitive pressure from Eli ...

While you may think you need expensive personal trainers, nutritionists or fancy gyms to lose weight, the truth is that technology has made it easier than ever to achieve your goals without breaking ...

Forbes Health has ranked the best providers for pricing, patient care, effectiveness and ease of use. This way you can cut through the scams and noise to make an informed decision when choosing an ...

The Danish company is trying to regain market share from Eli Lilly — which makes Mounjaro and Zepbound — by making its weight ...

Many people struggle to maintain a healthy weight, and choosing the optimal meals for weight loss can be challenging. A research team at the University of Illinois Urbana-Champaign has developed a ...

Tracking leads to weight loss: Why you might want a food tracking app. Whether your goal is to lose weight or improve your health, cut back on added sugar, fat or sodium, tracking your calories and ...

Tom Hanson is a national investigative correspondent for CBS News and Stations. His in-depth reports air across all platforms and programs. He is a member of CBS News and Stations Medical, Health, and ...

About one in eight adults (12%) say that they are currently taking a GLP-1 drug such as Ozempic or Wegovy either to lose weight or treat a chronic condition, an increase from 18 months ago, although ...

Eli Lilly’s experimental weight-loss pill could be fast-tracked under a one- to two-month review process recently launched by the U.S. Food and Drug Administration, several Wall Street analysts said.